289 related articles for article (PubMed ID: 31378552)
1. Clinical determinants of fever in clozapine users and implications for treatment management: A narrative review.
Verdoux H; Quiles C; de Leon J
Schizophr Res; 2019 Sep; 211():1-9. PubMed ID: 31378552
[TBL] [Abstract][Full Text] [Related]
2. When can patients with potentially life-threatening adverse effects be rechallenged with clozapine? A systematic review of the published literature.
Manu P; Sarpal D; Muir O; Kane JM; Correll CU
Schizophr Res; 2012 Feb; 134(2-3):180-6. PubMed ID: 22113154
[TBL] [Abstract][Full Text] [Related]
3. Clozapine Rechallenge After Major Adverse Effects: Clinical Guidelines Based on 259 Cases.
Manu P; Lapitskaya Y; Shaikh A; Nielsen J
Am J Ther; 2018; 25(2):e218-e223. PubMed ID: 29505490
[TBL] [Abstract][Full Text] [Related]
4. Clozapine-Associated Pulmonary Embolism: A High-Mortality, Dose-Independent and Early-Onset Adverse Effect.
Sarvaiya N; Lapitskaya Y; Dima L; Manu P
Am J Ther; 2018; 25(4):e434-e438. PubMed ID: 29985823
[TBL] [Abstract][Full Text] [Related]
5. Fever development in neuroleptic malignant syndrome during treatment with olanzapine and clozapine.
Szota A; Ogłodek E; Araszkiewicz A
Pharmacol Rep; 2013; 65(2):279-87. PubMed ID: 23744413
[TBL] [Abstract][Full Text] [Related]
6. Clozapine-induced cardiomyopathy and myocarditis monitoring: A systematic review.
Knoph KN; Morgan RJ; Palmer BA; Schak KM; Owen AC; Leloux MR; Patel M; Leung JG
Schizophr Res; 2018 Sep; 199():17-30. PubMed ID: 29548760
[TBL] [Abstract][Full Text] [Related]
7. Termination of clozapine treatment due to medical reasons: when is it warranted and how can it be avoided?
Nielsen J; Correll CU; Manu P; Kane JM
J Clin Psychiatry; 2013 Jun; 74(6):603-13; quiz 613. PubMed ID: 23842012
[TBL] [Abstract][Full Text] [Related]
8. Neuroleptic malignant syndrome and clozapine.
Reddig S; Minnema AM; Tandon R
Ann Clin Psychiatry; 1993 Mar; 5(1):25-7. PubMed ID: 8102300
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis, Interstitial Nephritis, and Pancreatitis in Association With Clozapine Treatment: A Systematic Review of Case Series and Reports.
Lally J; Al Kalbani H; Krivoy A; Murphy KC; Gaughran F; MacCabe JH
J Clin Psychopharmacol; 2018 Oct; 38(5):520-527. PubMed ID: 30059436
[TBL] [Abstract][Full Text] [Related]
10. Fever, confusion, acute kidney injury: is this atypical neuroleptic malignant syndrome following polypharmacy with clozapine and risperidone?
Cherry S; Siskind D; Spivak V; Wysoczanski D; Halangoda P
Australas Psychiatry; 2016 Dec; 24(6):602-603. PubMed ID: 27194777
[TBL] [Abstract][Full Text] [Related]
11. Clozapine-induced serositis: review of its clinical features, pathophysiology and management strategies.
Mouaffak F; Gaillard R; Burgess E; Zaki H; Olié JP; Krebs MO
Clin Neuropharmacol; 2009; 32(4):219-23. PubMed ID: 19620851
[TBL] [Abstract][Full Text] [Related]
12. Clozapine Associated with Autoimmune Reaction, Fever and Low Level Cardiotoxicity - A Case Report.
Gerasimou C; Vitali GP; Vavougios GD; Papageorgiou C; Douzenis A; Kokoris SI; Liappas I; Rizos E
In Vivo; 2017 Jan; 31(1):141-143. PubMed ID: 28064233
[TBL] [Abstract][Full Text] [Related]
13. A systematic review of clozapine-induced myocarditis.
Bellissima BL; Tingle MD; Cicović A; Alawami M; Kenedi C
Int J Cardiol; 2018 May; 259():122-129. PubMed ID: 29579587
[TBL] [Abstract][Full Text] [Related]
14. Clozapine and Fever: A Case of Continued Therapy With Clozapine.
Bruno V; Valiente-Gómez A; Alcoverro O
Clin Neuropharmacol; 2015; 38(4):151-3. PubMed ID: 26166236
[TBL] [Abstract][Full Text] [Related]
15. Characterization and clinical management of clozapine-induced fever.
Lowe CM; Grube RR; Scates AC
Ann Pharmacother; 2007 Oct; 41(10):1700-4. PubMed ID: 17785616
[TBL] [Abstract][Full Text] [Related]
16. Neuroleptic malignant-like syndrome and acute hepatitis during tolcapone and clozapine medication.
Blum MW; Siegel AM; Meier R; Hess K
Eur Neurol; 2001; 46(3):158-60. PubMed ID: 11598337
[No Abstract] [Full Text] [Related]
17. A Rational Use of Clozapine Based on Adverse Drug Reactions, Pharmacokinetics, and Clinical Pharmacopsychology.
de Leon J; Ruan CJ; Schoretsanitis G; De Las Cuevas C
Psychother Psychosom; 2020; 89(4):200-214. PubMed ID: 32289791
[TBL] [Abstract][Full Text] [Related]
18. Risks and benefits of clozapine and lithium co-prescribing: A systematic review and expert recommendations.
Verdoux H; Quiles C; de Leon J
Schizophr Res; 2024 Jun; 268():233-242. PubMed ID: 37002013
[TBL] [Abstract][Full Text] [Related]
19. Optimizing antidepressant and clozapine co-prescription in clinical practice: A systematic review and expert recommendations.
Verdoux H; Quiles C; de Leon J
Schizophr Res; 2024 Jun; 268():243-251. PubMed ID: 37852856
[TBL] [Abstract][Full Text] [Related]
20. Clozapine induced polyserositis.
Catalano G; Catalano MC; Frankel Wetter RL
Clin Neuropharmacol; 1997 Aug; 20(4):352-6. PubMed ID: 9260733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
